The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2004-814142PMID 14710369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of nuclear translocation of insulin

  2007cited by this paper
• Receptor tyrosine kinases: the main targets for new anticancer therapy.

  2003cited by this paper
• The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript*

  2003cited by this paper
• The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells*

  2003cited by this paper
• An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• The role of prolactin in mammary carcinoma.

  2003cited by this paper
• Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

  2003cited by this paper
• Glucose Regulates Insulin Gene Transcription by Hyperacetylation of Histone H4*

  2003cited by this paper
• Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo*

  2003cited by this paper
• Type 1 Insulin-like Growth Factor Receptor (IGF-IR) Signaling Inhibits Apoptosis Signal-regulating Kinase 1 (ASK1)*

  2003cited by this paper
• Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

  2003cited by this paper
• Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

  2003cited by this paper
• Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression.

  2003cited by this paper
• p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.

  2003cited by this paper
• Acute Control of Insulin-like Growth Factor-I Gene Transcription by Growth Hormone through Stat5b*

  2003cited by this paper
• Development of New Insulin-like Growth Factor-1 Receptor Kinase Inhibitors Using Catechol Mimics*

  2003cited by this paper
• The insulin-like growth factor system and cancer.

  2003cited by this paper
• Activating Transcription Factor 4 Overexpression Inhibits Proliferation and Differentiation of Mammary Epithelium Resulting in Impaired Lactation and Accelerated Involution*

  2003cited by this paper
• Augmented serum levels of the IGF-I/IGF-binding protein-3 ratio in pre-menopausal patients with type I breast cysts.

  2003cited by this paper
• Tyrosine kinases as targets in cancer therapy – successes and failures

  2003cited by this paper
• JNK-interacting Protein 1 Promotes Akt1 Activation*

  2003cited by this paper
• cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells

  2003cited by this paper
• A simple and cost-effective method for producing small interfering RNAs with high efficacy.

  2003cited by this paper
• Insulin‐like growth factor binding protein‐3 is overexpressed in endothelial cells of mouse breast tumor vessels

  2003cited by this paper
• IRS-4 mediated mitogenic signalling by insulin and growth hormone in LB cells, a murine T-cell lymphoma devoid of IGF-I receptors.

  2003cited by this paper
• RNAi as a gene therapy approach

  2003cited by this paper
• A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

  2003cited by this paper
• Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor Receptor*

  2002cited by this paper
• Nucleic-acid therapeutics: basic principles and recent applications

  2002cited by this paper
• Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

  2002cited by this paper
• Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.

  2002cited by this paper
• Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility.

  2002cited by this paper
• Suppression of Akt Signaling Induces Fas Ligand Expression: Involvement of Caspase and Jun Kinase Activation in Akt-Mediated Fas Ligand Regulation

  2002cited by this paper
• Insulin signaling pathways in time and space.

  2002cited by this paper
• Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

  2002cited by this paper
• Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.

  2002cited by this paper
• Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth

  2002cited by this paper
• Dominant negative alpha-subunit of FTase inhibits effects of insulin and IGF-I in MCF-7 cells.

  2002cited by this paper
• Differential Roles of Insulin Receptor Substrates in the Anti-apoptotic Function of Insulin-like Growth Factor-1 and Insulin*

  2002cited by this paper
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

  2002cited by this paper
• The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells.

  2002cited by this paper
• IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.

  2002cited by this paper
• P21Waf1 control of epithelial cell cycle and cell fate.

  2002cited by this paper
• Insulin‐like growth factor‐I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation

  2002cited by this paper
• Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

  2002cited by this paper
• Insulin-like Growth Factor I Induces MDM2-dependent Degradation of p53 via the p38 MAPK Pathway in Response to DNA Damage*

  2002cited by this paper
• Receptor tyrosine kinases as targets for anticancer drugs.

  2002cited by this paper
• RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix

  2002cited by this paper
• Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer.

  2002cited by this paper
• Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

  2002cited by this paper
• Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin

  2002cited by this paper
• PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

  2002cited by this paper
• Decreased expression of the mannose 6- phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Structural biology of insulin and IGF1 receptors: implications for drug design

  2002cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Genetic manipulation of the IGF-I axis to regulate mammary gland development and function.

  2002cited by this paper
• Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.

  2002cited by this paper
• Tyrosine kinases as targets for cancer therapy.

  2002cited by this paper
• Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.

  2002cited by this paper
• DNA methylation, chromatin boundaries, and mechanisms of genomic imprinting.

  2002cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

  2001cited by this paper
• The human histone deacetylase family.

  2001cited by this paper
• Molecular classification of breast cancer patients by gene expression profiling *

  2001cited by this paper
• Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines

  2001cited by this paper
• Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

  2001cited by this paper
• The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.

  2000cited by this paper
• The protein tyrosine kinase family of the human genome

  2000cited by this paper
• An alternative, nonapoptotic form of programmed cell death.

  2000cited by this paper
• A novel role for IRF-1 as a suppressor of apoptosis

  2000cited by this paper
• The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.

  2000cited by this paper
• Protein tyrosine kinase structure and function.

  2000cited by this paper
• IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation

  2000cited by this paper
• Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy.

  2000cited by this paper
• The insulin‐like growth factor‐1 elevates urokinase‐type plasminogen activator‐1 in human breast cancer cells: A new avenue for breast cancer therapy

  2000cited by this paper
• Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma.

  2000cited by this paper
• Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion

  1999cited by this paper
• Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

  1999cited by this paper
• The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.

  1999cited by this paper
• Synthetic peptide sequence from the C‐terminus of the insulin‐like growth factor‐I receptor that induces apoptosis and inhibition of tumor growth

  1999cited by this paper
• Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells

  1999cited by this paper
• IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.

  1999cited by this paper
• Insulin induces transcription of target genes through the hypoxia‐inducible factor HIF‐1α/ARNT

  1998cited by this paper
• Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.

  1998cited by this paper
• Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients

  1998cited by this paper
• Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.

  1997cited by this paper
• Nutrition, hormones, and breast cancer: Is insulin the missing link?

  1996cited by this paper
• Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide.

  1996cited by this paper
• The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling.

  1994cited by this paper
• Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum.

  1993cited by this paper
• Regulation of insulin‐like growth factor‐binding‐protein‐1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor‐negative human breast carcinoma cells

  1993cited by this paper
• Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1.

  1992cited by this paper
• Activation of transforming potential of the human insulin receptor gene.

  1987cited by this paper

• Prognostic Role of the DOK Family in Acute Myeloid Leukemia

  2023cites this paper
• NMR Methods for Structural Characterization of Protein-Protein Complexes

  2020cites this paper
• The effect of eight weeks aerobic exercise on cardiovascular and hormonal risk factors in breast cancer patients

  2018cites this paper
• Revisiting the IGF-1R as a breast cancer target

  2017cites this paper
• miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway

  2017cites this paper
• Ethnic Differences in Insulin Resistance as a Mediator of Cancer Disparities

  2014cites this paper
• Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programming.

  2013cites this paper
• Dietary Regulation of PTEN Signaling and Mammary Tumor Initiating Cells: Implications for Breast Cancer Prevention

  2012cites this paper
• Modifikation des Brustkrebsrisikos durch Bewegung

  2012cites this paper
• Diabetes and cancer II: role of diabetes medications and influence of shared risk factors

  2012cites this paper
• Novel Mechanism for Negatively Regulating Rho-Kinase (ROCK) Signaling through Coronin1B Protein in Neuregulin 1 (NRG-1)-induced Tumor Cell Motility*

  2012cites this paper
• Insulin-like Growth Factor-II Promotes Proliferation of Human Periodontal Ligament Fibroblasts via Expression of Early Growth Response Transcription Factors

  2012cites this paper
• Geburtshilfe / Frauen-Heilkunde / Strahlen-Heilkunde / Forschung / Konsequenzen

  2012cites this paper
• Papel de MVP en la reparación del ADN, la progresión tumoral y la hipoxia en carcinoma cervical: impacto pronóstico

  2011cites this paper
• Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer

  2011cites this paper
• Physical Activity and Breast Cancer : Prevention , Survival , and Mechanisms

  2010influential citation
• The Biological Mechanisms by Which Physical Activity Might Have an Impact on Outcome/Prognosis After a Breast Cancer Diagnosis

  2010cites this paper
• Structural Basis of Allosteric Ligand–Receptor Interactions in the Insulin/Relaxin Peptide Family

  2009cites this paper
• Development of multi-purpose microfluidic platform for single-cell and pairwise cell interaction assay.

  2009cites this paper
• Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.

  2008cites this paper
• The insulin receptor: a prototype for dimeric, allosteric membrane receptors?

  2008cites this paper
• Insulin and IGF-I Receptor Structure and Binding Mechanism

  2007cites this paper
• DOK4/IRS‐5 expression is altered in clear cell renal cell carcinoma

  2007cites this paper
• Employing Systems Biology to Quantify Receptor Tyrosine Kinase Signaling in Time and Space

  2007cites this paper
• Targeting the GH/IGF-1 axis with novel, small molecule inhibitors

  2007cites this paper
• RACK1 Recruits STAT3 Specifically to Insulin and Insulin-Like Growth Factor 1 Receptors for Activation, Which Is Important for Regulating Anchorage-Independent Growth

  2006cites this paper
• Effect of Insulin-like Growth Factor-I on the Expression of EGR-1 and -2 in Human Periodontal Ligament Fibroblasts

  2006cites this paper
• Cell-signalling dynamics in time and space

  2006cites this paper
• IGF-I mediated survival pathways in normal and malignant cells.

  2006cites this paper
• Molekulare Mechanismen der Wachstumswirkung des IGF-Systems

  2006cites this paper
• The IGF-1 receptor and its contributions to metastatic tumor growth—novel approaches to the inhibition of IGF-1R function

  2005cites this paper
• Altered expression of members of the IGF-axis in clear cell renal cell carcinoma.

  2005cites this paper
• Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment

  2004cites this paper
• Expression and regulation of the insulin‐like growth factor axis components in rat liver myofibroblasts

  2004cites this paper